Mesoblast Limited Successful Bone Marrow Regeneration In Cancer Patients Using Cord Blood Expanded By Proprietary Stem Cells

Published: Nov 09, 2009

Melbourne, Nov 6, 2009 (ABN Newswire) - Mesoblast Limited's (ASX:MSB)(PINK:MBLTY) today announced successful results from the first 18 patients receiving a bone marrow transplant using umbilical cord blood expanded by the patented allogeneic, or "off-the-shelf", Mesenchymal Precursor Cells (MPCs).

Back to news